BC’s COVID-19 Response
Temporary Authorizations for Controlled Drugs and Substances
[Update - December 2, 2021]
Transfers from Other Provinces
In November 2021, Health Canada issued an update to the Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada to allow transfers of controlled substances prescriptions between provinces.
The FAQ document has been similarly updated to state that “prescriptions under this exemption can be transferred to another province or territory”
[Update - April 7, 2020]
Additional temporary amendments to Professional Practice Policy-71: Delivery of Opioid Agonist Treatment (PPP-71) that allow pharmacists to authorize regulated health professionals to deliver Opioid Agonist Treatment (OAT), are now in effect.
These temporary amendments also allow pharmacists to authorize pharmacy employees, including pharmacy technicians and pharmacy assistants, to deliver OAT on a pharmacist’s behalf in exceptional circumstances where it is not possible for a pharmacist or other regulated health professional to deliver the OAT drug.
BC's COVID-19 Response
The situation regarding COVID-19 continues to evolve here in BC, Canada and other jurisdictions in the world. The College of Pharmacists of BC is working closely with the Ministry of Health and other partners to support the response to this new illness as part of BC’s health system.
The College will provide any updated information or guidance for pharmacy professionals as it becomes available.
Please follow updates provided on bcpharmacists.org/COVID19
Pharmacy professionals exhibiting COVID-19 symptoms should follow the COVID-19 testing process developed for all British Columbia health care workers.
Amendments to the Pharmacy Operations and Drug Scheduling Act Bylaws and the Community Pharmacy Standards of Practice to allow temporary exemptions for prescriptions of controlled substances are now in effect.
To support continuity of care to patients during the COVID-19 Pandemic, Health Canada has issued temporary exemptions for prescriptions of controlled substances, to maintain Canadians’ access to controlled substances as needed for medical treatments.
Controlled Drugs and Substances Act - Subsection 56(1) Class Exemption for Patients, Practitioners and Pharmacists Prescribing and Providing Controlled Substances in Canada During the Coronavirus Pandemic.
These temporary exemptions, made under the Controlled Drugs and Substances Act (CDSA) will:
- Permit pharmacists to extend and renew prescriptions
- Permit pharmacists to transfer prescriptions to other pharmacists;
- Permit prescribers to verbally prescribe prescriptions with controlled substances; and
- Allow pharmacy employees to deliver prescriptions of controlled substances to patients at their homes or an alternate location.
- [Update - April 7, 2020]: This amendment is not listed below. On April 7, 2020, the College Board approved temporary amendments to Professional Practice Policy - 71: Delivery of Opioid Agonist Treatment that allow pharmacists to authorize regulated health professionals to deliver Opioid Agonist Treatment (OAT). These amendments also allow pharmacy employees, including pharmacy technicians and pharmacy assistants, to deliver OAT on a pharmacist’s behalf in exceptional circumstances where it is not possible for a pharmacist or other regulated health professional to deliver the OAT drug.)
In order to reduce barriers and immediately implement these exemptions within BC’s current regulatory framework, the College Board has reviewed and amended both the Pharmacy Operations and Drug Scheduling Act (PODSA) Bylaws, as well as the Community Pharmacy Standards of Practice.
Providing Emergency Supplies of Controlled Drugs and Substances
BC’s pharmacies have already been directed by Minister of Health, Adrian Dix and B.C. Provincial Health Officer, Dr. Bonnie Henry, to provide refills of regular prescriptions in an effort to avoid non-essential physicians and nurse practitioners visits and free these practitioners to treat COVID-19 cases.
The College is asking pharmacists to act in the best interests of patients who require access to controlled drugs and substances (including Opioid Agonist Therapy) by providing emergency supplies to patients with expired prescriptions.
Section 19(7)(d) of the College’s Bylaws under the Pharmacy Operations and Drug Scheduling Act and Professional Practice Policy 31 – Emergency Supply for Continuity of Care already align with Health Canada’s exemption to permit pharmacists to extend and renew prescriptions. Pharmacists are able to provide emergency supplies to patients with expired prescriptions, including narcotics, psychiatric drugs and anti-psychotics for chronic conditions. The policy provides broad latitude for pharmacist decisions on emergency supplies, provided it is in the patient’s best interest and all decisions are properly documented with rationale.
TRANSFERRING PRESCRIPTIONS TO OTHER PHARMACISTS
The College Board has amended Section 8(3)(a) of the Community Pharmacy Standards of Practice to allow for the transfer of a prescription for controlled drug substances to other pharmacies licenced in British Columbia.
(Amendments listed in bold text)
Community Pharmacy Standards of Practice - Prescription Copy and Transfer
PERMITTING VERBAL ORDERS FOR A NEW PRESCRIPTION OR TO EXTEND OR REFILL AN EXISTING PRESCRIPTION
The College Board has amended Section 19(6) of the Pharmacy Operations and Drug Scheduling Act (PODSA) Bylaws to permit pharmacists to dispense drugs included in the controlled prescription program upon receiving a verbal order from a practitioner, if doing so is permitted under a section 56 exemption to the Controlled Drugs and Substances Act.
It is important to note that when taking verbal prescriptions in community practice, a registrant must make a written record of the verbal authorization in accordance with Section 6(7) of the Community Pharmacy Standards of Practice, as well as applicable federal legislation.
This written record MUST include:
- The pharmacist’s signature or initial
- The name of the practitioner providing the verbal order
- The practitioner’s college identification number
(Amendments listed in bold text)
Pharmacy Operations and Drug Scheduling Act (PODSA) Bylaws - Sale and Disposal of Drugs
FAXING OF CONTROLLED PRESCRIPTION PROGRAM FORMS
The College Board has also amended Section 7(3) of the Community Pharmacy Standards of Practice to allow pharmacists to dispense prescriptions received by facsimile transmission for drug referred to on the Controlled Prescription Drug List in exceptional circumstances.
The pharmacy must receive the original prescription form, by mail or any other appropriate method, from the practitioner as soon as reasonably possible.
(Amendments listed in bold text)
Community Pharmacy Standards of Practice - Transmission by Facsimile
*Note: Any method by which a prescriber can safely provide the original form to the pharmacy is appropriate.
As a result of these amendments, additional consequential amendments have been made to the following Professional Practice Policy Guides:
- PPP-66 Policy Guide: Buprenorphine/Naloxone Maintenance Treatment (2018)
- PPP-66 Policy Guide: Methadone Maintenance Treatment (2013)
- PPP-66 Policy Guide: Slow Release Oral Morphine Maintenance (SROM) Treatment (2018)
- PPP-67 Policy Guide: Injectable Hydromorphone Maintenance Treatment (2018)
Delivering Prescriptions for Controlled Drugs and Substances
Under Health Canada’s temporary exemption, pharmacy employees in British Columbia are permitted to deliver prescriptions of controlled substances on behalf of a pharmacist (excluding opioid agonist treatment) to patients at their homes or alternate locations. Delivery of controlled substances by pharmacy employees must meet the requirements set out in the temporary exemption. At this time, only pharmacists in British Columbia are permitted to deliver opioid agonist treatment, and must do so in accordance with Professional Practice Policy – 71: Delivery of Opioid Agonist Treatment.
Recent amendments to Professional Practice Policy – 71: Delivery of Opioid Agonist Treatment allow a pharmacist to deliver Opioid Agonist Treatment to a patient if they feel it is safe, appropriate and in the best interest of the patient.
For everyone’s health and safety, those delivering medications should confirm if the patient is experiencing symptoms of COVID-19 or are self-isolating prior to delivering medications. In addition, they should consider how to maintain social distancing while delivering medications to a patient.
FREQUENTLY ASKED QUESTIONS
For further clarification on the scope of the exemption for providing controlled substances during the coronavirus pandemic, please refer to the following FAQs provided by Health Canada:
For questions related to pharmacy practice in BC and continuity of care for patients with substance use disorder, see the College of Pharmacists COVID-19 resource page, and the following FAQs.
- Pharmacy staff are concerned about transmission surrounding Opioid Agonist Treatment (OAT) and the accountability log. Can we forgo the patient signature to maintain social distancing?
- We are receiving requests for delivery of Opioid Agonist Treatment (OAT) from patients self-isolating. What are my responsibilities? How to we prevent transmission?
Health Canada recognizes that local pandemic precautions may impact the operations of Supervised Consumption Sites (SCS), and are committed to working directly with SCS Operators to assess each individual situation and develop appropriate modifications to their protocols and practices. Operators are encouraged to contact the Office of Controlled Substances’ Exemptions Section at:
If you have any questions, please contact Health Canada’s Office of Controlled Substances, at:
For additional questions related to pharmacy practice and providing continuity of care for patients during this emergency, contact the College’s practice support at [email protected].
|This article was updated for clarity on March 30, 2020|